Akt isoform-specific signaling in breast cancer: Uncovering an anti-migratory role of palladin

Cell Adhesion and Migration

Volumn 5, Issue 3, 2011, Pages

  Chin, Y Rebecca ^a   Toker, Alex ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Akt isoforms; Breast cancer; Metastasis; Migration; Palladin

Indexed keywords

ACTIN; ANDROGEN RECEPTOR; BETA1 INTEGRIN; INITIATION FACTOR 4E; INTERLEUKIN ENHANCER BINDING FACTOR 2; MAMMALIAN TARGET OF RAPAMYCIN; MERLIN; MK 2206; PALLADIN PROTEIN; PERIFOSINE; PROTEIN; PROTEIN KINASE B; SHORT HAIRPIN RNA; SOMATOMEDIN C RECEPTOR; TRICIRIBINE; TUBERIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; ISOPROTEIN; PALLADIN PROTEIN, HUMAN; PHOSPHOPROTEIN;

ALLELE; BIOCHEMISTRY; BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; CELL MIGRATION; CELL MOTILITY; CELL SURVIVAL; CYTOSKELETON; DEREGULATION; FIBROBLAST; GENE MUTATION; HETEROZYGOSITY LOSS; KNOCKOUT MOUSE; MOLECULAR GENETICS; NONHUMAN; ONCOGENE; PHENOTYPE; PROTEIN PHOSPHORYLATION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY; TUMOR GROWTH; UPREGULATION; BREAST TUMOR; FEMALE; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

BREAST NEOPLASMS; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; PHOSPHOPROTEINS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84555191987     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Bellacosa A, Testa JR, Staal SP, Tsichlis PN. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 1991; 254:274-7. (Pubitemid 21917339)
2. Altomare DA, Testa JR. Perturbations of the AKT signaling pathway in human cancer. Oncogene 2005; 24:7455-64. (Pubitemid 41637985)
3. Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006; 7:606-19. (Pubitemid 44100518)
4. Hutchinson J, Jin J, Cardiff RD, Woodgett JR, Muller WJ. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol 2001; 21:2203-12. (Pubitemid 32479640)
5. Sun M, Wang G, Paciga JE, Feldman RI, Yuan ZQ, Ma XL, et al. AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol 2001; 159:431-7. (Pubitemid 32751073)
6. Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 2004; 428:332-7. (Pubitemid 38418805)
7. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005; 4:988-1004.
8. Kim D, Cheng GZ, Lindsley CW, Yang H, Cheng JQ. Targeting the phosphatidylinositol-3-kinase/Akt pathway for the treatment of cancer. Curr Opin Investig Drugs 2005; 6:1250-8. (Pubitemid 43009206)
9. Gills JJ, Dennis PA. Perifosine: update on a novel Akt inhibitor. Curr Oncol Rep 2009; 11:102-10.
10. Lindsley CW. The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation: a 2009 update. Curr Top Med Chem 2010; 10:458-77.
11. Hutchinson JN, Jin J, Cardiff RD, Woodgett JR, Muller WJ. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res 2004; 64:3171-8. (Pubitemid 38581419)
12. Maroulakou IG, Oemler W, Naber SP, Tsichlis PN. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res 2007; 67:167-77. (Pubitemid 46142772)
13. Ju X, Katiyar S, Wang C, Liu M, Jiao X, Li S, et al. Akt1 governs breast cancer progression in vivo. Proc Natl Acad Sci USA 2007; 104:7438-43. (Pubitemid 47185924)
14. Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 2005; 20:539-50. (Pubitemid 41668639)
15. Irie HY, Pearline RV, Grueneberg D, Hsia M, Ravichandran P, Kothari N, et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 2005; 171:1023-34. (Pubitemid 41815834)
16. Liu H, Radisky DC, Nelson CM, Zhang H, Fata JE, Roth RA, et al. Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. Proc Natl Acad Sci USA 2006; 103:4134-9.
17. Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, Ayala R, et al. Overexpression of AKT2/protein kinase Bbeta leads to upregulation of beta1 integrins, increased invasion and metastasis of human breast and ovarian cancer cells. Cancer Res 2003; 63:196-206. (Pubitemid 36070440)
18. Dillon RL, Marcotte R, Hennessy BT, Woodgett JR, Mills GB, Muller WJ. Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression. Cancer Res 2009; 69:5057-64.
19. Chin YR, Toker A. Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. Cell Signal 2009; 21:470-6.
20. Woodgett JR. Recent advances in the protein kinase B signaling pathway. Curr Opin Cell Biol 2005; 17:150-7. (Pubitemid 40380938)
21. Villen J, Beausoleil SA, Gerber SA, Gygi SP. Large-scale phosphorylation analysis of mouse liver. Proc Natl Acad Sci USA 2007; 104:1488-93. (Pubitemid 46214617)
22. Obata T, Yaffe MB, Leparc GG, Piro ET, Maegawa H, Kashiwagi A, et al. Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J Biol Chem 2000; 275:36108-15.
23. Chin YR, Toker A. The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration. Mol Cell 2010; 38:333-44.
24. Dixon RD, Arneman DK, Rachlin AS, Sundaresan NR, Costello MJ, Campbell SL, et al. Palladin is an actin cross-linking protein that uses immunoglobulin-like domains to bind filamentous actin. J Biol Chem 2008; 283:6222-31.
25. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007; 129:1261-74. (Pubitemid 46962095)
26. Tang X, Jang SW, Wang X, Liu Z, Bahr SM, Sun SY, et al. Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation. Nat Cell Biol 2007; 9:1199-207. (Pubitemid 47500497)
27. Lin HK, Wang L, Hu YC, Altuwaijri S, Chang C. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J 2002; 21:4037-48. (Pubitemid 34857436)
28. Chin YR, Toker A. Akt2 regulates expression of the actin-bundling protein palladin. FEBS Lett 2010; 584:4769-74.
29. Goicoechea SM, Bednarski B, Garcia-Mata R, Prentice-Dunn H, Kim HJ, Otey CA. Palladin contributes to invasive motility in human breast cancer cells. Oncogene 2009; 28:587-98.
30. Meulmeester E, Ten Dijke P. The dynamic roles of TGF-beta in cancer. J Pathol 2010; 223:205-18.
31. Kurisu S, Takenawa T. WASP and WAVE family proteins: friends or foes in cancer invasion? Cancer Sci 2010; 101:2093-104.